MedTrace Logo

Pulsed Shortwave Therapy Adjunct Pain and Recovery in Total Knee Replacement

NCT03395444 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-06-08

No results posted yet for this study

Summary

This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following total knee replacement. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.

Conditions

  • Total Knee Arthroplasty

Interventions

DEVICE

pulsed shortwave therapy

Pulsed shortwave therapy us the RecoveryRx device. Emits a pulsed signal a the 27.12Mhz wavelength

Sponsors & Collaborators

  • BioElectronics Corporation

    lead INDUSTRY

Principal Investigators

  • Omar Tabbouche, Pharm D · New Mazloum Hospital

  • Raed El Hassan, Dr · New Mazloum Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-15
Primary Completion
2018-12-15
Completion
2019-03-15

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03395444 on ClinicalTrials.gov